Bin Liu
3D-bioprinted Functional and Biomimetic Hydrogel Scaffolds Incorporated with Nanosilicates to Promote Bone Healing In vivo
报告人:Bin Liu
所在单位:Xijing Hospital, Fourth Military Medical University
Biography:
Bin Liu is an attending doctor in Department of Orthopedics, General Hospital of Northern Theater Command, Shenyang, China. He received his bachelor’s degree (2013) from University of South China, and master’s (2016) and doctorate degrees (2020) from Fourth Military Medical University (with Prof. Guoxian Pei). Bin Liu’s research interests focus on 3D bioprinting, injectable hydrogels and bone tissue engineering. His main work has been published in Material Science and Engineering C, RSC Advances, Cell Adhesion & Migration, among other journals.
Abstract：
Three-dimensional (3D) bioprinting is an extremely convenient biofabrication technique for creating biomimetic tissue-engineered bone constructs and has promising applications in regenerative medicine. However, existing bioinks have shown low mechanical strength, poor osteoinductive ability, and lacking a suitable microenvironment for laden cells. Nanosilicate (nSi) has shown to be a promising biomaterial, due to its unique properties such as excellent biocompatibility, degrade into nontoxic products, and with osteoinductive properties, which has been used in bone bioprinting. However, the long term bone healing effects and associating risks, if any, of using nSi in tissue engineering bone scaffolds in vivo are unclear and require a more thorough assessment prior to practical use. Hence, a functional and biomimetic nanocomposite bioink composed of rat bone marrow mesenchymal stem cells (rBMSCs), nSi, gelatin and alginate for the 3D bioprinting of tissue-engineered bone constructs is firstly demonstrated, mimicking the structure of extracellular matrix, to create a conducive microenvironment for encapsulated cells. It is shown that the addition of nSi significantly increases the printability and mechanical strength of fabricated human-scale tissue or organ structures (up to 15 mm height) and induces osteogenic differentiation of the encapsulated rBMSCs in the absence of in vitro osteoinductive factors. A systematic in vivo research of the biomimetic nanocomposite bioink scaffolds is further demonstrated in a rat critical-size (8 mm) bone defect-repair model. The in vivo results demonstrate that the 3D bioprinted nanocomposite scaffolds can significantly promote the bone healing of the rat calvarial defects compared to other scaffolds without nSi or cells, and show rarely side effects on the recipients. Given the above advantageous properties, the 3D bioprinted nanocomposite scaffolds can greatly accelerate the bone healing in critical bone defects, thus providing a clinical potential candidate for orthopedic applications.
